A Phase II Trial of O6-Benzylguanine [benzylguanine] (NSC 637037) and BCNU (Carmustine) in Patients With Advanced Soft Tissue Sarcoma

Trial Profile

A Phase II Trial of O6-Benzylguanine [benzylguanine] (NSC 637037) and BCNU (Carmustine) in Patients With Advanced Soft Tissue Sarcoma

Completed
Phase of Trial: Phase II

Latest Information Update: 07 Feb 2013

At a glance

  • Drugs Benzylguanine (Primary) ; Carmustine (Primary)
  • Indications Sarcoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 10 Sep 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top